WBA
38
3
TGNA
66
-6
ZTS
65
2
HD
47
9
BMY
33
-2
PGR
67
-2
DVA
72
-3
KIM
48
-6
CSCO
51
-7
GE
61
-4
MAR
50
6
ROK
40
-3
GWW
55
-9
RF
51
-2
EMC
50
-39
SO
82
-2
CVS
41
2
AVY
75
-3
AMAT
60
-3
CB
54
7
WBA
38
3
TGNA
66
-6
ZTS
65
2
HD
47
9
BMY
33
-2
PGR
67
-2
DVA
72
-3
KIM
48
-6
CSCO
51
-7
GE
61
-4
MAR
50
6
ROK
40
-3
GWW
55
-9
RF
51
-2
EMC
50
-39
SO
82
-2
CVS
41
2
AVY
75
-3
AMAT
60
-3
CB
54
7
Financhill
Back

TG Therapeutics Stock Predictions

Buy
68

TGTX
TG Therapeutics

Last Price:
17.43
Seasonality Move:
1.6%

7 Day Trial

ALL ACCESS PASS

$ 7

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 25.6% based on the past 27 years of stock performance.
  • TG Therapeutics has risen higher in 10 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.04%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $17.42. The Score for TGTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • TGTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 25.6% based on the past 27 years of stock performance.

TG Therapeutics Stock Rating

Buy
68
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 10 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.04%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
31.54
52-Week Low:
6.46

Prediction Charts

Market Cap:
2.69B
Price in USD:
17.42
Volume:
2.02M
Beta:
0.89

Technical Analysis

SMA50:
15.36
SMA100:
15.74
SMA200:
13.23
52-Wk Change:
-42.68%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 17.42 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 13.66 13.32 13.85 13.22
Apr-30 13.30 13.66 13.75 12.93
May-1 17.15 15.85 18.00 14.87
May-2 16.20 16.42 16.76 15.55
May-3 16.75 16.19 17.00 15.96
May-6 16.26 16.51 16.63 15.76
May-7 16.50 17.17 17.28 16.42
May-8 16.99 17.12 17.63 16.98
May-9 17.23 16.92 17.34 16.83
May-10 16.91 16.62 17.13 16.60
May-13 16.75 17.32 17.57 16.63
May-14 17.51 17.96 18.37 17.51
May-15 18.29 17.72 18.41 17.63
May-16 17.72 17.42 17.74 17.29

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.06 per share, and an increase next year of $0.68 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.